Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

NEW ORLEANS (AP) — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ...

Many doctors and health plans, however, hold safety and cost control concerns about a labeling change. Celebrex and Vioxx cost roughly 20 times more than ibuprofren, and insurers believe that a ...

GAITHERSBURG, Md. — Pfizer Inc. should get American approval to market its Celebrex arthritis-pain pill for use in children because the benefits outweigh the risks, a Food and Drug Administration ...

NEW ORLEANS – Pfizer Inc's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and naproxen, and does not appear to ...

The Chinese State Food and Drug Administration (SFDA) advised patients to be cautious when using the drug Celebrex for treating osteoarthritis. The warning follows the release of a study that shows ...

Jeffrey Brown talks with health correspondent Susan Dentzer and Dr. John Reveille, director of the Division of Rheumatology at the University of Texas Health Science Center in Houston, about the ...

Confronting the drug safety debate head-on, Pfizer will advertise its pain pill Celebrex to consumers for the first time in two years. The medicine, along with rival Vioxx from Merck , became a poster ...

New prescriptions for Pfizer Inc.'s arthritis drug Celebrex plunged 56 percent for the week ending Dec. 24, after news the drug may increase the risk of heart attacks and strokes. And on Monday, a ...